Vanda Pharmaceuticals (VNDA) FCF Margin (2010 - 2026)
Vanda Pharmaceuticals' FCF Margin was -61.87% in Q2 2026, down 32.30 percentage points from -29.57% a year earlier but up 35.66 percentage points from the prior quarter.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) FCF Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vanda Pharmaceuticals' FCF Margin was -66.29% through Jun 30, 2026, down 33.90 percentage points year-over-year; for FY2025, it was -51.10%, down 42.93 percentage points from FY2024.
- FCF Margin has now declined for four consecutive years, with a five-year change of -71.24 percentage points (FY2020 to FY2025).
- In earlier years, FCF Margin was -8.17% in FY2024 (-14.62 pp), 6.45% in FY2023 (-5.86 pp), 12.31% in FY2022 (-11.39 pp) and 23.69% in FY2021 (+3.55 pp).
- Quarterly FCF Margin has moved between -97.53% (Q1 2026) and 50.80% (Q1 2023) over five years.
- Compared with a year earlier, FCF Margin has declined for six straight quarters, with an average year-over-year change of -31.92 percentage points over the last eight quarters.
- The best year-over-year quarter for FCF Margin over five years was Q1 2023 (a gain of 44.21 percentage points); the worst was Q1 2025 (a drop of 83.04 percentage points).
- Per Business Quant data, VNDA's FCF Margin in the three quarters before Q2 2026 was -97.53% (Q1 2026), -51.59% (Q4 2025) and -56.50% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Vanda Pharmaceuticals | 312.55 Mn | -617.39 Mn | 46.97 Mn | -61.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -61.87% |
| Mar 31, 2026 | -97.53% |
| Dec 31, 2025 | -51.59% |
| Sep 30, 2025 | -56.50% |
| Jun 30, 2025 | -29.57% |
| Mar 31, 2025 | -67.11% |
| Dec 31, 2024 | -3.82% |
| Sep 30, 2024 | -30.94% |
| Jun 30, 2024 | -13.94% |
| Mar 31, 2024 | 15.93% |
| Dec 31, 2023 | -8.80% |
| Sep 30, 2023 | -5.34% |
| Jun 30, 2023 | -28.82% |
| Mar 31, 2023 | 50.80% |
| Dec 31, 2022 | 14.19% |
| Sep 30, 2022 | 19.43% |
| Jun 30, 2022 | 8.53% |
| Mar 31, 2022 | 6.60% |
| Dec 31, 2021 | 38.92% |
| Sep 30, 2021 | 13.42% |
API Access
Vanda Pharmaceuticals FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();